What does SANGAMO THERAPEUTICS, INC (SGMO) do?

SANGAMO THERAPEUTICS, INC (SGMO) is a publicly traded company in the Healthcare sector.

What sector does SGMO operate in?

SANGAMO THERAPEUTICS, INC operates in the Healthcare, specifically within the Biotech industry. AlphaOS tracks cycle stage, supply-chain relationships, and investment intelligence for companies across all sectors.

Where can I find SGMO earnings analysis?

AlphaOS publishes an earnings intelligence page for SANGAMO THERAPEUTICS, INC (SGMO) covering results, guidance context, and AI-assisted analysis. See /stocks/SGMO/earnings. Content is for research and education — not investment advice.

Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

SGMO

SANGAMO THERAPEUTICS, INC

Healthcare · Biotech

$0.18Jun 22, 2026

AI confidence 70% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

SANGAMO THERAPEUTICS, INC shows decelerating business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue -78% YoY in Q1 FY2026.

TrajectoryDecelerating

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

Revenue -78% YoY in Q1 FY2026

Pipeline evidence · 1d ago

SGMO's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on SGMO.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q1 2026

Full SGMO earnings analysis

Reported figures for SANGAMO THERAPEUTICS, INC — research only, not investment advice.

Revenue YoY: -77.6%

Latest Intelligence

Updated September 29, 2026

What happened recently for SANGAMO THERAPEUTICS, INC (SGMO) — events, not interpretation.

Event: Reported Q1 2026 revenue -78% YoY.
Also: Last session June 22, 2026 at $0.18.
Source: Q1 2026 earnings

Research & analysis only — not investment advice.

Building company intelligence…

SANGAMO THERAPEUTICS, INC (SGMO)

Healthcare · Biotech

Investment Snapshot above is the primary AlphaOS analysis for SANGAMO THERAPEUTICS, INC — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:: Healthcare
Industry:: Biotech
Market cap:: $73.58M
Revenue:: $1.44M

SGMO earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow SANGAMO THERAPEUTICS, INC through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Related & Connected

Connected companies and research pages from the AlphaOS knowledge graph.